Lab Reference Library / Karyotype Genetic Markers

Karyotype

Q: What is a karyotype test?

A karyotype test analyzes the complete set of chromosomes from a cell sample (typically peripheral blood lymphocytes). Cells are cultured, arrested in metaphase (when chromosomes are most condensed and visible), stained with Giemsa dye (G-banding), and photographed under a microscope. The resulting image shows all 46 chromosomes arranged in pairs by size and banding pattern. This allows identification of missing or extra chromosomes, structural rearrangements (translocations, deletions, inversions), and sex chromosome composition.

Q: When is karyotype testing indicated?

Premature ovarian insufficiency (POI) in women under 40 (to identify Turner syndrome mosaicism or other X chromosome abnormalities), primary amenorrhea (absence of menstruation by age 16), recurrent pregnancy loss (two or more miscarriages, to identify balanced translocations in either partner), ambiguous genitalia or disorders of sex development, suspected sex chromosome disorders (short stature with webbed neck suggesting Turner, tall stature with small testes suggesting Klinefelter), and male infertility with azoospermia or severe oligospermia.

Q: What is Turner syndrome?

Turner syndrome results from complete or partial absence of one X chromosome in females. The classic karyotype is 45,X (monosomy X), but many cases are mosaic (45,X/46,XX), meaning some cells have two X chromosomes and others have only one. Turner syndrome causes short stature, ovarian failure (streak gonads leading to POI and infertility), cardiac defects (bicuspid aortic valve, coarctation of the aorta), renal anomalies, and webbed neck. Mosaic Turner syndrome can present with milder features, including isolated POI without the classic physical findings.

Q: What is Klinefelter syndrome?

Klinefelter syndrome results from the presence of an extra X chromosome in males, producing a karyotype of 47,XXY. It affects approximately 1 in 600 males and is the most common sex chromosome aneuploidy. Clinical features include tall stature, small firm testes, gynecomastia, reduced facial and body hair, infertility (azoospermia in most cases), and increased risk of metabolic syndrome, osteoporosis, and autoimmune disease. Many cases are undiagnosed until infertility evaluation. Testosterone replacement is typically required.

Q: What is a mosaic karyotype?

A mosaic karyotype means that two or more chromosomally distinct cell populations exist in the same individual. For example, 45,X/46,XX mosaicism means some cells have one X chromosome (Turner) and others have two (normal female). Mosaicism produces a spectrum of clinical severity depending on the proportion and tissue distribution of abnormal cells. A woman with 90% normal cells and 10% monosomy X cells may have only mild POI, while a woman with 70% monosomy X cells may have classic Turner features. Standard karyotype analyzes 20 to 30 cells; low-level mosaicism may require FISH or microarray for detection.

Chromosome Analysis · Cytogenetic Analysis · G-Banded Karyotype

Reference interpretation, clinical significance, and why karyotype analysis is the definitive test for chromosomal number and structural abnormalities. Essential for evaluating premature ovarian insufficiency, recurrent pregnancy loss, primary amenorrhea, ambiguous genitalia, and suspected sex chromosome disorders including Turner syndrome and Klinefelter syndrome.

Genetic TestChromosomal Analysis

Normal Female46,XX

Normal Male46,XY

SamplePeripheral blood

Turnaround10 to 21 days

← Back to Lab Reference Library

Category: Genetic Markers | Also known as: Chromosome Analysis, Cytogenetic Analysis, G-Banded Karyotype | Sample: Peripheral blood (heparin tube); results in 10 to 21 days

1. What This Test Measures

A karyotype is a visual representation of the complete set of chromosomes from a single cell, arranged in standardized pairs by size, centromere position, and banding pattern. Human cells normally contain 46 chromosomes: 22 pairs of autosomes (numbered 1 through 22) and one pair of sex chromosomes (XX in females, XY in males). To produce a karyotype, peripheral blood lymphocytes are cultured in the laboratory, stimulated to divide, arrested in metaphase (the stage of cell division when chromosomes are maximally condensed and visible), and stained with Giemsa dye to produce a characteristic banding pattern (G-banding) on each chromosome.

The G-banding pattern is unique to each chromosome and allows cytogeneticists to identify each chromosome pair, detect missing or extra chromosomes (aneuploidy), and identify structural rearrangements including translocations (exchange of segments between non-homologous chromosomes), deletions (loss of a chromosome segment), inversions (reversal of a segment within a chromosome), and duplications (extra copy of a segment). Standard karyotype resolution detects abnormalities of approximately 5 to 10 megabases or larger. Smaller deletions or duplications require higher-resolution techniques such as fluorescence in situ hybridization (FISH) or chromosomal microarray analysis (CMA).

The karyotype is a one-time, definitive test: an individual's constitutional karyotype does not change over their lifetime. Once a normal karyotype is confirmed, it does not need to be repeated. An abnormal karyotype has lifelong clinical implications for the patient and potentially for their family members.

2. Why This Test Matters

Premature ovarian insufficiency: karyotype is recommended for all women diagnosed with POI before age 40 because Turner syndrome mosaicism (45,X/46,XX) is a common cause of ovarian failure that may present with no classic physical features other than early menopause and low AMH
Recurrent pregnancy loss: approximately 3 to 5% of couples with two or more miscarriages carry a balanced chromosomal translocation in one partner. The translocation produces no phenotype in the carrier but generates unbalanced gametes (eggs or sperm with missing or extra chromosomal segments) that produce chromosomally abnormal embryos
Primary amenorrhea: absence of menstruation by age 16 warrants karyotype to identify Turner syndrome (45,X), androgen insensitivity syndrome (46,XY with female phenotype), and other disorders of sex development
Male infertility: karyotype is indicated for men with azoospermia (no sperm) or severe oligospermia (very low sperm count) to identify Klinefelter syndrome (47,XXY), the most common sex chromosome aneuploidy in males, and Y chromosome structural abnormalities
Ambiguous genitalia and disorders of sex development: karyotype determines chromosomal sex and guides the clinical evaluation of atypical genital development
Suspected sex chromosome disorders: short stature with webbed neck and shield chest (Turner syndrome), tall stature with small testes and gynecomastia (Klinefelter syndrome), or other features suggestive of sex chromosome aneuploidy
Family planning after translocation identification: carriers of balanced translocations benefit from preimplantation genetic testing (PGT-SR) during IVF to select embryos with balanced or normal chromosome complements

3. Standard Reference Results

Karyotype	Classification	Clinical Significance
46,XX	Normal female	22 autosome pairs + two X chromosomes; normal chromosomal complement
46,XY	Normal male	22 autosome pairs + one X and one Y chromosome; normal chromosomal complement
45,X	Turner syndrome (monosomy X)	Missing one X chromosome; ovarian failure, short stature, cardiac anomalies
45,X/46,XX	Mosaic Turner syndrome	Mixed cell populations; variable phenotype depending on proportion of monosomy X cells
47,XXY	Klinefelter syndrome	Extra X in males; small testes, infertility, tall stature, gynecomastia
46,XX,t(...)	Balanced translocation (female)	No phenotypic effect in carrier; risk of unbalanced offspring causing miscarriage or birth defects
46,XY,t(...)	Balanced translocation (male)	No phenotypic effect in carrier; risk of unbalanced gametes

4. Clinical Interpretation by Context

Clinical Context	Expected Finding if Abnormal	Next Steps
POI (woman under 40)	45,X or 45,X/46,XX mosaicism	Cardiology referral (aortic screening), endocrinology, bone density, renal ultrasound
Recurrent miscarriage	Balanced translocation in one partner	Genetic counseling; IVF with PGT-SR for future pregnancies
Primary amenorrhea	45,X; 46,XY (androgen insensitivity); other DSD	Specialized DSD evaluation; endocrinology; gonadal assessment
Male infertility (azoospermia)	47,XXY (Klinefelter)	Testosterone replacement; fertility counseling (testicular sperm extraction may be possible)
Normal karyotype	46,XX or 46,XY	Chromosomal cause excluded; pursue other diagnostic pathways (FMR1, microarray if indicated)

Mosaicism requires clinical correlation: a karyotype reporting 45,X/46,XX with 15% monosomy X cells may explain isolated POI in a woman with no other Turner features. The same mosaicism with 60% monosomy X cells would be expected to produce short stature, cardiac screening needs, and more severe ovarian failure. The proportion of abnormal cells determines the clinical impact, and standard karyotype (20 to 30 cells analyzed) may underestimate low-level mosaicism.

5. Karyotype in the Complete Reproductive and Genetic Panel

Marker	What It Adds	When to Order
Karyotype (this page)	Chromosomal number and structure; sex chromosome composition	POI, recurrent loss, amenorrhea, infertility, suspected DSD
AMH	Ovarian reserve quantification; low in Turner and POI	Any cycle day
FSH	Pituitary response to ovarian failure; elevated in POI	Cycle day 2 to 3
FMR1	Fragile X premutation; genetic cause of POI distinct from chromosomal	Unexplained POI, family history
Adrenal Antibodies	Autoimmune POI evaluation; polyendocrine screening	When autoimmune etiology suspected
Total Testosterone	Androgen status in Klinefelter; hyperandrogenism in DSD	Any time

6. Symptoms and Presentations That Prompt Karyotype Testing

Female Presentations

Premature menopause (before age 40) with no other explanation
Primary amenorrhea (no menstruation by age 16)
Short stature with delayed puberty
Webbed neck, shield chest, widely spaced nipples (Turner features)
Lymphedema of hands and feet in newborn females
Recurrent miscarriages (two or more)
Low AMH with no identifiable cause in a young woman
Cardiac anomaly (bicuspid aortic valve) with short stature

Male Presentations

Azoospermia or severe oligospermia on semen analysis
Small, firm testes on examination
Gynecomastia (breast tissue development in males)
Tall stature with eunuchoid body proportions
Reduced facial and body hair with low testosterone
Learning difficulties or attention problems (Klinefelter associated)
Osteoporosis or low bone density in a young male
Ambiguous genitalia at birth or during puberty

7. Chromosomal Abnormalities and Their Mechanisms

Monosomy X (Turner syndrome, 45,X): results from non-disjunction during parental gametogenesis or early embryonic cell division. The missing X chromosome eliminates the genes required for normal ovarian development and maintenance. Streak gonads (fibrous tissue replacing functional ovarian tissue) develop, producing primary or premature ovarian failure
Mosaic Turner (45,X/46,XX): post-zygotic non-disjunction produces two cell lines. The phenotype depends on the proportion of monosomy X cells in critical tissues (ovary, heart, kidneys). Women with low-level mosaicism may have normal puberty and menstruation but experience premature ovarian failure in their 20s or 30s
Klinefelter syndrome (47,XXY): extra X chromosome from non-disjunction during parental gametogenesis. The additional X produces excess estrogen receptor activity and testicular fibrosis through mechanisms that are not fully elucidated. Sertoli cell dysfunction leads to azoospermia; Leydig cell dysfunction leads to testosterone deficiency
Balanced translocations: two chromosomes exchange segments without net loss or gain of genetic material. The carrier is phenotypically normal but produces gametes with unbalanced chromosome complements (partial trisomy or monosomy) in approximately 50% of conceptions, leading to recurrent miscarriage or offspring with chromosomal syndromes
Robertsonian translocations: a specific type of balanced translocation involving the fusion of two acrocentric chromosomes (13, 14, 15, 21, 22). The most common is rob(13;14). Carriers have 45 chromosomes but a functionally complete genome. Risk of unbalanced offspring depends on the specific chromosomes involved
Y chromosome microdeletions: not detected by standard karyotype (requires molecular testing). Deletions in the AZF (azoospermia factor) regions of the Y chromosome cause spermatogenic failure and are the second most common genetic cause of male infertility after Klinefelter syndrome

8. Clinical Management by Karyotype Finding

Turner Syndrome (45,X or Mosaic)

Cardiac screening: echocardiogram and cardiac MRI to evaluate for bicuspid aortic valve (present in 15 to 30%), coarctation of the aorta, and aortic root dilation. Lifetime surveillance required
Renal ultrasound: horseshoe kidney and other renal anomalies occur in approximately 30% of Turner patients
Hormone replacement: estrogen and progesterone replacement starting at puberty (if classic) or at POI onset (if mosaic) to support bone density, cardiovascular health, and urogenital tissue
Bone density monitoring: DEXA scan at baseline and every 2 to 3 years; estrogen replacement and vitamin D optimization are essential
Fertility counseling: donor egg IVF is the primary fertility option for most Turner patients. Some mosaic Turner women may have residual oocytes; early AMH assessment guides fertility preservation decisions

Klinefelter Syndrome (47,XXY)

Testosterone replacement: most Klinefelter men require lifelong testosterone therapy starting in late adolescence or early adulthood. Optimizes energy, bone density, muscle mass, libido, and metabolic health
Fertility assessment: while most 47,XXY men are azoospermic, micro-TESE (testicular sperm extraction) can retrieve sperm in approximately 40 to 50% of cases for use with IVF/ICSI. Earlier intervention (before age 35) improves retrieval rates
Bone density: Klinefelter men have increased osteoporosis risk due to testosterone deficiency and excess estrogen receptor activity. DEXA monitoring and testosterone replacement are essential
Metabolic monitoring: increased risk of metabolic syndrome, type 2 diabetes, and cardiovascular disease. Monitor fasting insulin, HbA1c, and lipids
Gynecomastia management: breast tissue development is common and may require surgical treatment if symptomatic. Aromatase inhibitor therapy may be considered

Balanced Translocations

Genetic counseling: essential for all translocation carriers and their partners. Detailed risk assessment based on the specific chromosomes involved, the breakpoints, and the type of translocation (reciprocal vs Robertsonian)
IVF with PGT-SR: preimplantation genetic testing for structural rearrangements screens embryos for unbalanced chromosomal complements before transfer. Selects embryos with balanced or normal karyotypes, dramatically reducing miscarriage risk
Family cascade testing: balanced translocations are inherited. First-degree relatives of the carrier should be offered karyotyping to identify other carriers who may be at risk of recurrent miscarriage or unbalanced offspring
Prenatal testing options: if natural conception is pursued, chorionic villus sampling (CVS) or amniocentesis can evaluate fetal karyotype in each pregnancy
Emotional support: recurrent pregnancy loss with a translocation diagnosis carries significant psychological burden. Referral to support groups and counseling is an important component of comprehensive care

9. Related Lab Tests

FSHElevated in Ovarian and Testicular Failure

→

EstradiolLow in POI; Elevated Relative to T in Klinefelter

→

Total TestosteroneLow in Klinefelter; Guides Replacement

→

LHElevated in Primary Gonadal Failure

→

DHEA-SAdrenal Androgen Reserve Assessment

→

Vitamin DBone Health in Turner and Klinefelter

→

10. When Testing Is Recommended

Women with premature ovarian insufficiency (menopause before age 40): to identify Turner syndrome mosaicism as the cause
Primary amenorrhea (no menstruation by age 16): to determine chromosomal sex and identify sex chromosome abnormalities
Recurrent pregnancy loss (two or more miscarriages): karyotype both partners to identify balanced translocations
Male infertility with azoospermia or severe oligospermia: to identify Klinefelter syndrome (47,XXY)
Clinical features suggestive of Turner syndrome: short stature, webbed neck, shield chest, delayed puberty, cardiac anomalies
Clinical features suggestive of Klinefelter syndrome: tall stature, small firm testes, gynecomastia, low testosterone
Ambiguous genitalia or atypical sexual development at any age
After POI diagnosis with negative FMR1 premutation testing: karyotype identifies Turner mosaicism as the next most common genetic cause

11. Clinical Perspective

Clinical Perspective

Karyotype is not a test I order frequently, but when the clinical picture calls for it, it is irreplaceable. A 36-year-old woman with an AMH of 0.3 and elevated FSH has premature ovarian insufficiency. The question is why. If FMR1 premutation testing is negative, the next step is karyotype. Mosaic Turner syndrome (45,X/46,XX) is one of the most common genetic causes of POI in young women, and many of these women have no classic Turner physical features. They look completely typical. The only clue is their ovaries failing 15 years earlier than expected. Identifying Turner mosaicism changes the clinical trajectory: they need cardiac screening (bicuspid aortic valve, aortic dilation), renal imaging, bone density monitoring, and a fertility conversation that includes the realistic options of donor egg IVF. The karyotype is a simple blood draw, but the information it provides shapes the next 30 years of that patient's medical care.

Brian Lamkin, DO | Founder, The Lamkin Clinic | Edmond, Oklahoma

12. Frequently Asked Questions

What is a karyotype test?

Analysis of the complete chromosome set from blood lymphocytes. Cells are cultured, arrested in metaphase, stained (G-banding), and photographed. Identifies missing or extra chromosomes, structural rearrangements (translocations, deletions, inversions), and sex chromosome composition. Normal: 46,XX (female) or 46,XY (male). One-time, definitive test.

When is karyotype testing indicated?

Premature ovarian insufficiency (Turner mosaicism), primary amenorrhea (sex chromosome identification), recurrent pregnancy loss (balanced translocations in either partner), male infertility with azoospermia (Klinefelter), ambiguous genitalia, and suspected sex chromosome disorders. Also after negative FMR1 testing in unexplained POI.

What is Turner syndrome?

Complete or partial absence of one X chromosome (45,X or mosaic 45,X/46,XX). Causes short stature, ovarian failure (streak gonads), cardiac defects (bicuspid aortic valve, coarctation), and renal anomalies. Mosaic Turner can present with isolated POI and no classic physical features. Requires cardiac screening, bone density monitoring, and hormone replacement.

What is Klinefelter syndrome?

Extra X chromosome in males (47,XXY). Affects approximately 1 in 600 males. Tall stature, small firm testes, gynecomastia, reduced body hair, infertility (azoospermia), increased metabolic syndrome and osteoporosis risk. Many undiagnosed until infertility evaluation. Requires testosterone replacement. Micro-TESE sperm retrieval possible in approximately 40 to 50% of cases.

What is a mosaic karyotype?

Two or more chromosomally distinct cell populations in the same individual (e.g., 45,X/46,XX). Produces a spectrum of clinical severity depending on the proportion and tissue distribution of abnormal cells. Standard karyotype analyzes 20 to 30 cells; low-level mosaicism may require FISH or microarray. The proportion determines the clinical impact.

Content authored and clinically reviewed by Brian Lamkin, DO, founder of The Lamkin Clinic in Edmond, Oklahoma. Brian Lamkin, DO has 25+ years of experience in functional and regenerative medicine. This page reflects current functional medicine practice standards and is updated as new clinical evidence becomes available.

A karyotype is a simple blood draw that shapes the next 30 years of medical care.

Chromosomal analysis identifies the genetic causes of premature ovarian failure, recurrent pregnancy loss, and infertility that standard hormonal testing cannot detect. When the question is structural, the karyotype is the answer. Schedule a consultation at The Lamkin Clinic.

Schedule a Consultation

Medical Disclaimer: This content is provided for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Genetic testing requires pre-test and post-test genetic counseling to ensure proper interpretation and informed decision-making. Lab interpretation should always be performed by a qualified healthcare provider. Schedule a consultation to discuss genetic testing with Brian Lamkin, DO.